| 000 | 01853 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514165255.0 | ||
| 264 | 0 | _c20040311 | |
| 008 | 200403s 0 0 eng d | ||
| 022 | _a1590-1874 | ||
| 024 | 7 |
_a10.1007/s10072-003-0190-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuggieri, R M | |
| 245 | 0 | 0 |
_aLong-term interferon-beta treatment for multiple sclerosis. _h[electronic resource] |
| 260 |
_bNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology _cDec 2003 |
||
| 300 |
_a361-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDisability Evaluation |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Administration Routes |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon beta-1a |
| 650 | 0 | 4 | _aInterferon beta-1b |
| 650 | 0 | 4 |
_aInterferon-beta _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 650 | 0 | 4 |
_aPatient Compliance _xstatistics & numerical data |
| 650 | 0 | 4 |
_aPatient Dropouts _xstatistics & numerical data |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSettipani, N | |
| 700 | 1 | _aViviano, L | |
| 700 | 1 | _aAttanasio, M | |
| 700 | 1 | _aGiglia, L | |
| 700 | 1 | _aAlmasio, P | |
| 700 | 1 | _aLa Bella, V | |
| 700 | 1 | _aPiccoli, F | |
| 773 | 0 |
_tNeurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology _gvol. 24 _gno. 5 _gp. 361-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10072-003-0190-3 _zAvailable from publisher's website |
| 999 |
_c14444960 _d14444960 |
||